Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;24(17):13383.
doi: 10.3390/ijms241713383.

Association between Human Leukocyte Antigen and End-Stage Renal Disease in Patients from Transylvania, Romania

Affiliations

Association between Human Leukocyte Antigen and End-Stage Renal Disease in Patients from Transylvania, Romania

Luminita-Ioana Iancu Loga et al. Int J Mol Sci. .

Abstract

End-stage renal disease (ESRD) is the final stage of chronic kidney disease. This study explored the association between human leukocyte antigen (HLA) and ESRD. The interaction between genetic and environmental factors may also play a role in the development of ESRD. The study included 2392 ESRD patients who were awaiting renal transplantation. Blood samples were genotyped by SSOP and SSP-PCR methods. Multivariate logistic regression analysis showed that HLA-A*11 (p = 0.027), HLA-A*34 (p = 0.017), HLA-A*69 (p = 0.012), HLA-B*41 (p < 0.001), HLA-B*50 (p = 0.004), HLA-DRB1*10 (p = 0.027), and HLA-DRB1*14 (p = 0.004) were positively associated with ESRD (OR > 1); HLA-DRB1*07 (p < 0.001), HLA-DRB1*08 (p = 0.005), and HLA-DRB1*13 (p < 0.001) were protective against ESRD (OR < 1); and the three-locus haplotype HLA-A*02-B*41-DRB1*03, containing one susceptible allele, was strongly associated with ESRD (p < 0.001, OR = 3.15). In conclusion, this retrospective analysis of HLA typing in patients with ESRD of various etiologies suggests that molecular data on the HLA polymorphism should be collected in order to identify high-risk ESRD patients and to improve graft survival after kidney transplantation.

Keywords: allele frequency; end-stage renal disease; haplotype frequency; human leukocyte antigen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. KDIGO Conference Participants Genetics in chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2022;101:1126–1141. doi: 10.1016/j.kint.2022.03.019. - DOI - PMC - PubMed
    1. Chen T.K., Knicely D.H., Grams M.E. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019;322:1294–1304. doi: 10.1001/jama.2019.14745. - DOI - PMC - PubMed
    1. Pop C., Gheorghe Fronea O.F., Branea I.A., Itu L.M., Darabont R., Parepa I., Benedek T., Dorobantu M. Prevalence and Predictors of Renal Disease in a National Representative Sample of the Romanian Adult Population: Data from the SEPHAR IV Survey. Diagnostics. 2022;12:3199. doi: 10.3390/diagnostics12123199. - DOI - PMC - PubMed
    1. Cepoi V., Onofriescu M., Segall L., Covic A. The prevalence of chronic kidney disease in the general population in Romania: A study on 60,000 persons. Int. Urol. Nephrol. 2012;44:213–220. doi: 10.1007/s11255-011-9923-z. - DOI - PubMed
    1. Cao Q., Xie D., Liu J., Zou H., Zhang Y., Zhang H., Zhang Z., Xue H., Zhou J., Chen P. HLA polymorphism and susceptibility to end-stage renal disease in Cantonese patients awaiting kidney transplantation. PLoS ONE. 2014;9:e90869. doi: 10.1371/journal.pone.0090869. - DOI - PMC - PubMed